Los mejores oncohematólogos del tratamiento de Linfoma no Hodgkin — TOP-67 médicos

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

El Dr. Andrés JM Ferreri es médico oncólogo con más de 300 artículos científicos publicados relacionados con el tratamiento de linfomas. Es Director Adjunto del Departamento de Hematología Oncológica y Director de la Unidad de Linfoma del Instituto Científico San Raffaele, así como Fundador de la Fundación Italiana de Linfoma. Es miembro de varias organizaciones médicas de prestigio y Profesor Contratado de Oncología en la Università Vita-Salute San Raffaele.

El profesor Bosch es un líder de gran reputación en leucemia linfocítica crónica (LLC) y lleva a cabo investigaciones clínicas y básicas sobre la LLC y otros trastornos linfoproliferativos, centrándose en la patogenia molecular de la LLC y nuevos enfoques terapéuticos. Ha publicado más de 100 artículos en revistas de prestigio y es profesor de hematología en el Hospital Universitario Vall d'Hebron de Barcelona.

Hematólogo-oncólogo pediátrico, especialista en trasplante de médula ósea

oncohematólogo

Profesor, Especialista en Hematología y Trasplantología

Especialista en hematología. Se especializa en el tratamiento de linfomas.

oncólogo pediátrico

Oncohematólogo, un destacado especialista en trasplante de médula ósea

El Dr. Yener Koc es un especialista en trasplante de médula ósea altamente experimentado y galardonado, formado en los EE. UU. Ha realizado más de 1.900 trasplantes y ha logrado tasas de supervivencia a largo plazo del 66 al 90 % para diversas afecciones, con una tasa de mortalidad del 0,5 al 9 %. Es autor de más de 230 publicaciones científicas y es inspector de los Centros Europeos de Trasplante de Médula Ósea desde 2004.